Change Agents (CHGA)

Its consumer health technology activities include distribution of the Keto Air breathalyzer in North America. The device is marketed as a non-invasive way for consumers to measure ketosis levels, making it relevant to users following ketogenic diets or monitoring nutrition-related wellness goals. This segment places Avalon GloboCare in the broader market for at-home health and lifestyle monitoring tools, where ease of use and consumer adoption are key considerations.

The company also operates in artificial intelligence content technology. Through its AI-focused subsidiary, Avalon GloboCare works on systems for automated short-form video generation, enterprise documentation, and workflow automation. These tools are designed to help businesses create content, streamline internal processes, and reduce manual work through generative and automation technologies. The AI segment reflects a shift toward software-enabled products that can be sold into business and digital media use cases.

Avalon GloboCare’s profile differs from larger healthcare or software companies because it spans early-stage commercial opportunities rather than one mature operating vertical. For investors, ALBT is tied to execution risk, product adoption, and the company’s ability to turn its consumer health and AI platforms into sustainable revenue streams. Its shares are therefore most closely associated with speculative growth themes in wellness technology and applied artificial intelligence.